Impaired placentation
- “Kidney-Sparing” in Brain-sparing Growth Restricted Fetuses
- A biophysical index versus maternal age for preeclampsia risk classification at 11-14 weeks’ gestation in a developing country population
- A pilot competing risks model for small for gestational age in early and middle adolescent pregnancies of a developing country population
- A population-specific competing risks model for preeclampsia screening at 11-14 weeks’ gestation by maternal characteristics
- A simplified Bayesian algorithm for preeclampsia screening at 11-14 weeks’ gestation in a developing country population
- A study of “The transverse versus the sagittal approach” in second-trimester uterine artery Doppler measurement
- Accuracy of sonographic bone age for gestational age estimation
- Accuracy of sonographic fetal weight estimation near delivery
- Accuracy of sonographic weight estimation in fetal macrosomia
- Adverse outcome in intrauterine growth deviation from second to third trimester in severely obese women
- Altered lipid metabolism in late-onset fetal growth restriction revealed by LC-MS/MS proteomics analysis
- Amniotic fluid index measurements and correlation to fetal biometric parameters
- Analysis of the population screening for preeclampsia at the Hospital Universitario San Juan de Alicante during 2021
- Angiogenic factors for planning fetal surveillance in fetal growth restriction and small-for-gestational-age fetuses
- Antenatal detection of SGA: What happens with false positives and false negatives?
- Biochemical markers of cardiac and placental dysfunction in pregnancies with fetal smallness and preeclampsia
- Birthweight reference standards at the federal university of Rio de Janeiro
- Changes in maternal gut microbiota profiling due to a life-style intervention during pregnancy
- Circulating micro RNA as biomarkers of preeklampsia
- Definition of normal blood pressure at 11-14 weeks according to the competing risk of preeclampsia
- Detection of false positives from first-trimester screening for preeclampsia at the second trimester of pregnancy (STOP-PRE trial)
- Detection of free ß-hCG, PAPP-A, PlGF and sFlt-1 in capillary blood
- Ductus venous Doppler in the assessment with a number of biomarkers in the prediction of preeclampsia at 11-13 weeks of gestation
- Effectiveness of low-dose aspirin for the prevention of preeclampsia in twin pregnancy
- Efficacy of Ecospirin 150 mg in prevention of preeclampsia and FGR in a high risk North Indian cohort
- Efficacy of low-dose aspirin in prevention of preterm preeclampsia among low risk twin gestations
- Estimated Fetal Weight below 3rd centile in the context of IUGR and adverse outcome
- Evaluation of home blood pressure self-measurements in a high-risk collective
- Evaluation of maternal placental growth factor in suspected pre-eclamptic women
- Evaluation of the incidence of preeclampsia by identifying diseases, ultrasound and biochemical markers
- External Validation of Fetal Medicine Foundation Algorithm for prediction of Pre-eclampsia
- External validation of the new model for prediction of small for gestational age neonate from biophysical and biochemical markers at 11–14 weeks’ gestation
- External validation of the new model for prediction of small for gestational age neonate from maternal characteristics and medical history
- Fetal cardiac remodeling according to lifestyle intervention. A subanalysis of the IMPACT BCN trial
- Fetal growth throughout gestation in women who underwent a life-style program during pregnancy
- Fetal programming: Increased Neurofilament and MR-proANP levels in umbilical cord blood by fetal growth restriction as a sign of neuronal injury and heart failure
- First trimester biochemistry and Low birth weight babies: Screening beyond aneuploidies
- First-trimester screening for preeclampsia and small-for-gestational-age: A comparison of the Gaussian and FMF algorithms
- Functional and structural changes in left ventricle during pregnancy hypertension
- Genetic and Neurodevelopmental Assessment in Non-placental Extremely Small-for-Gestational Age Infants Born at Term
- High risk of genetic disorders in early severe fetal growth restriction
- Hypertensive disorders of pregnancy: a natural peripartum maternal cardiovascular stress test
- Impact of first trimester screening for preeclampsia in women having conceived through assisted reproductive techniques
- Incidence of hypertensive disorders of pregnancy in Romania
- Influence of activated complement and coagulation cascades on endothelial cell dysfunction in early-onset preeclampsia
- Inter-arm blood pressure difference in early pregnancy and risk of preeclampsia
- Interdisciplinary, transsectoral and multiprofessional care of fetuses, pregnant women and children in preeclampsia and fetal growth restriction
- Is ultrasonographic prediction of birth weight from 28 weeks better than from 32 weeks?
- Liver functionalism tests and maternal complications in preeclamptic patients
- Low birth weight and prematurity as determinants of severe phenotype in carriers of hypertrophic cardiomyopathy mutations
- Lung function in adults born small for gestational age at term
- Machine learning algorithms for the prediction of preterm preeclampsia
- Management of late-onset fetal growth restriction: an evidence based approach
- Management of pregnacies at high risk of preeclampsia or/and fetal growth restriction
- Maternal anti-inflammatory diet profile at 20 weeks is associated with a lower risk of Small for Gestational Age newborns in a Mediterranean area
- Maternal hemodynamic parameters in uncomplicated pregnancy and its changes in pregnancy complicated by hypertensive disorder
- Maternal serum angiogenic factor sFlt-1/PlGF ratio in hypertensive disorders in pregnancy using ThermoFisher KRYPTOR
- Mortality and severe neurological morbidity of extremely preterm intrauterine growth restricted infants
- Ophthalmic artery Doppler as a clinical tool in preeclampsia: why does it work? A proof of principle
- Optimum fetal growth: Is this a myth ?
- Outcome of late fetal growth restricted babies according to risk stratification in a novel evidence based fetal growth restriction clinic
- Pathophysiological pathways in early-onset severe preeclampsia and their interactions revealed by metabolomics analysis
- PE-like syndrome confirmed in a larger cohort
- Performance of cerebral/placental–uterine Doppler ratio in the prediction of adverse perinatal outcome in fetuses with growth alterations
- Placental levels of annexin V, C3b, C4d, and C5b-9 in placentas of patients with lupus, antiphospholipid syndrome and non-criteria-obstetric antiphospholipid syndrome with and without adverse pregnancy outcomes
- Predicting the risk of persistent postpartum hypertension using clinical and peripartum echocardiographic findings
- Prediction and diagnosis of fetal growth restriction
- Prediction of adverse maternal and fetal outcome in preeclampsia using a risk prediction model
- Prediction of neonatal respiratory morbidity assessed by quantitative ultrasound lung texture analysis in small for gestational age fetuses
- Predictive value of 24-hour proteinuria in neonatal outcome in preeclamptic women
- Predictive values of ratio sFlt-1/PlGF for occurrence of early onset and late onset preeclampsia
- Preeclampsia prevention: Performance of FMF protocol compared with Gestosis score
- Preeclampsia screening in Denmark (PRESIDE); A national implementation study
- Preeclampsia screening in Denmark (PRESIDE); A national implementation study
- Prevention of late preeclampsia with a Mediterranean diet intervention during pregnancy
- Pulmonary vascular reactivity in growth restricted fetuses: computational modelling and machine learning analysis of fetal Doppler waveforms
- Questionnaire survey to examine pregnant women’s attitude towards first trimester screening for preeclampsia
- Reproducibility of ultrasound fetal Dopplers in fetal growth assessment
- Results of the Prospective Registry of Patients with Hypertensive disorders of pregnancy in a city center from Buenos Aires
- Revealed versus concealed criteria for placental insufficiency in an unselected obstetric population in late pregnancy
- Second trimester sFlt1/PlGF ratio for the prediction of adverse outcomes
- Severe hypercholanaemia occurring at later gestational weeks is associated with increased stillbirth risk in intrahepatic cholestasis of pregnancy
- Sex differences in the effect of mediterranean diet or mindfulness-based stress reduction on prevention of small for gestational age newborns
- SFlt-1 for the prediction of adverse maternal outcomes in women with SARS-CoV-2 infection and hypertensive disorders of pregnancy
- SFlt-1 to PlGF ratio cutoffs to predict adverse pregnancy outcomes in early-onset FGR and SGA: a prospective observational study
- Skeletal growth is reduced in low PAPP-A pregnancies independent of placental dysfunction
- Small for gestational age fetuses prevalence in coviod-19 pandemic 2020 at large district general hospital in London UK
- Sonographic fetal weight prediction of macrosomia in severely obese pregnant women with Body Mass Index ≥35
- Stillbirth Aftercare in a Tertiary Obstetric Center - Parents´ Experiences
- The association between abnormal antenatal Doppler indices in UA and adverse outcome of IUGR neonates
- The competing risks approach for preeclampsia prediction in early and middle adolescent pregnancies of a developing country population
- The effect of a prophylaxis protocol with aspirin on the prevalence and perinatal repercussions of preeclampsia
- The effect of mediterranean diet or mindfulness-based stress reduction on placental histopathological lesions
- The IMPACT BCN Randomized Clinical Trial: effects of mediterranean diet or stress reduction of adverse perinatal outcome in high-risk pregnant women
- The IMPACT BCN trial for the prevention of SGA newborns: sub analysis according to maternal BMI
- The influence of anti-coagulant therapy in the first trimester uterine flow indices
- The profile of angiogenic factors in preeclampsia and fetal growth restriction and its correlation with alpha-1-microglobulin
- The role of ductus venosus blood flow velocities in I and II trimester of pregnancy in prediction of the fetal and neonatal condition
- The role of Placental Growth Factor, soluble Endoglin and PlGF/sENG ratio in pregnancy complicated by preeclampsia
- Unique cardiac remodeling in young adults born Small for Gestational Age with subsequent central obesity
- Validation of the Fetal Medicine Foundation 4.0 algorithm for preeclampsia screening at 11-14 weeks’ gestation adapted to a Mexican population
- Variations in incidence and clinical presentation of preeclampsia according to method of data collection and diagnostic criteria in a Danish cohort
- Which screening method is most suitable for preeclampsia in the first trimester? A model-based impact study